DHX37 and lung adenocarcinoma: Similarly, the poor outcome [28] in liver hepatocellular carcinoma (OS (overall survival) HR = 1.6, 95%CI = 1.06 to 2.42, P = 0.025; RFS HR = 1.23, 95%CI = 0.87 to 1.73, P = 0.23) and lung adenocarcinoma (OS HR = 1.83, 95%CI = 1.27 to 2.64, P = 0.00095; RFS HR = 1.25, 95%CI = 0.79 to 1.96, P = 0.34) was shown to be relevant to higher DHX37 expression (Figures 2(i), 2(j), 2(m), and 2(n)).